Differential drug response in pulmonary arterial hypertension: The potential for precision medicine

Pulmonary arterial hypertension (PAH) is a rare, complex, and deadly cardiopulmonary disease. It is characterized by changes in endothelial cell function and smooth muscle cell proliferation in the pulmonary arteries, causing persistent vasoconstriction, resulting in right heart hypertrophy and fail...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Elise, Sampson, Chinwuwanuju Ugo‐Obi, Desai, Ankit A., Karnes, Jason H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621006/
https://www.ncbi.nlm.nih.gov/pubmed/37927610
http://dx.doi.org/10.1002/pul2.12304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621006/
https://www.ncbi.nlm.nih.gov/pubmed/37927610
http://dx.doi.org/10.1002/pul2.12304

Ejemplares similares